Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 clients • 6 examiners • 4 art units • 0 of 6 (0%) have an AI response strategy ready
Rivkin Radler LLP has 6 pending office actions in Biotechnology & Pharmaceuticals and 264 career applications. Its resolved allowance rate is 78.74%, indicating that allowance was achieved in a smaller portion of the reported resolved matters than the other outcome category.
The firm averages 2.48 office actions per allowance. Allowed matters therefore generally involved repeated examination interaction. The application record is focused, making the profile most useful for evaluating this practice’s reported biotechnology and pharmaceutical work. Practitioners should weigh the current docket and action-per-allowance measure alongside the less favorable resolved allowance result.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 6 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
| LEE, ANDREW P | 1 | 48.5% | +22.8% |
| DALE, ABIGAYLE ANN | 1 | 44.0% | +70.1% |
| SCHLIENTZ, LEAH H | 1 | 41.8% | +38.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18268555 | Side Port For Addition Of Multiple Drugs To A Nebulizer | DALE, ABIGAYLE ANN | 44d overdue |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 39d |
| 18781717 | USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING | DONOHUE, SEAN R | — |
| 18741551 | SECOND NEAR-INFRARED ORGANIC FLUORESCENT PROBE, PREPARATION METHOD AND USE THEREOF | MOSHER, ERIC PARKER | — |
| 18703281 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | CRAIG, KAILA ANGELIQUE | — |
| 18490503 | DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY | LEE, ANDREW P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18268555 | Side Port For Addition Of Multiple Drugs To A Nebulizer | DALE, ABIGAYLE ANN | 44d overdue |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 39d |
| 18781717 | USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING | DONOHUE, SEAN R | — |
| 18703281 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | CRAIG, KAILA ANGELIQUE | — |
| 18490503 | DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY | LEE, ANDREW P | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Inner Mongolia University | 2 |
| Blue Wave Therapeutics GmbH | 1 |
| Aleta Neuroscience, LLC | 1 |
| InspiRx, Inc. | 1 |
| UNIVERSITY OF COPENHAGEN | 1 |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| 1612 | 1 |
| 1691 | 1 |
| 3785 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18781717 | USE OF SECOND NEAR-INFRARED ORGANIC FLUORESCENT COMPOUND IN PREPARATION OF BIOIMAGING CONTRAST AGENT AND IN VASCULAR FLUORESCENCE IMAGING | Inner Mongolia University | DONOHUE, SEAN R | 1618 | §102§103§112 | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18741551 | SECOND NEAR-INFRARED ORGANIC FLUORESCENT PROBE, PREPARATION METHOD AND USE THEREOF | Inner Mongolia University | MOSHER, ERIC PARKER | 1612 | §103§112Other | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18703281 | PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES | Blue Wave Therapeutics GmbH | CRAIG, KAILA ANGELIQUE | 1618 | §103§112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18490503 | DRUG COCKTAIL FOR TREATMENT OF PARKINSON'S DISEASE, LEWY BODY DISEASE AND MULTIPLE SYSTEM ATROPHY | Aleta Neuroscience, LLC | LEE, ANDREW P | 1691 | §102§103 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18268555 | Side Port For Addition Of Multiple Drugs To A Nebulizer | Inspirx, Inc. | DALE, ABIGAYLE ANN | 3785 | §102§103§112 | Final Rejection | 44d overdue | Pending | Jun 20, 2023 |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | UNIVERSITY OF COPENHAGEN | SCHLIENTZ, LEAH H | 1618 | §103§112 | Non-Final OA | 39d | Pending | Feb 16, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.7% of resolved applications prosecuted by Rivkin Radler LLP were allowed, across 264 applications in USPTO records.
2.48 office actions per allowed application on average.
6 pending office actions as of October 2026, for 5 clients, before 6 examiners in 4 art units.
